NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
NewcelX Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026
$2.63+0.13 (+5.20%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 1.2
- Dividend yield
- –
NewcelX statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | NewcelX | Industry median |
|---|---|---|
| Market Cap | $12.62M | $166.30M |
| Enterprise Value | $11.91M | $88.19M |
| PE Ratio | 1.22 | 20.44 |
| PB Ratio | 2.09 | 2.03 |
| P/TBV Ratio | 2.93 | 2.29 |
Income (trailing twelve months)
| Measure | NewcelX | Industry median |
|---|---|---|
| Operating Income | -$2.56M | -$21.40M |
| Net Income | -$8.30M | -$22.46M |
| EBITDA | -$2.51M | -$16.91M |
| EPS (Diluted) | $2.16 | -$0.83 |
Returns
| Measure | NewcelX | Industry median |
|---|---|---|
| Return on Assets (ROA) | -118.3% | -40.9% |
Growth
| Measure | NewcelX | Industry median |
|---|---|---|
| EPS Growth (YoY) | -11.1% | -26.2% |
Balance sheet
| Measure | NewcelX | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $710.00K | $61.43M |
| Net Cash (Debt) | $710.00K | $15.35M |
| Net Cash Per Share | $0.15 | $0.66 |
| Equity (Book Value) | $6.04M | $49.09M |
| Book Value Per Share | $1.26 | $1.37 |
| Tangible Book Value | $4.31M | $23.52M |
Cash flow (trailing twelve months)
| Measure | NewcelX | Industry median |
|---|---|---|
| Operating Cash Flow | -$2.77M | -$12.35M |
| Capital Expenditures | -$8.00K | -$1.08M |
| Free Cash Flow | -$2.77M | -$20.22M |
| FCF Per Share | -$0.58 | -$0.42 |
Efficiency
| Measure | NewcelX | Industry median |
|---|---|---|
| Profits Per Employee | -$691.67K | -$703.34K |
| Employee Count | 12 | 74 |
Dividends and yields
| Measure | NewcelX | Industry median |
|---|---|---|
| Earnings Yield | -65.8% | -23.3% |
| FCF Yield | -22.0% | -8.72% |
Shares
| Measure | NewcelX | Industry median |
|---|---|---|
| Shares Outstanding | 4,797,510 | 58,127,000 |
| Shares Change (YoY) | 29.9% | 10.9% |
| Float | 1,612,360 | 49,136,700 |
| Shares Held by Insiders | 66.4% | 11.6% |
Scores
| Measure | NewcelX | Industry median |
|---|---|---|
| Graham Number | $7.82 | $18.73 |
| Graham Upside | 197.4% | -45.1% |
| Altman Z-Score | -11.86 | -0.22 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from NewcelX's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.